The aim of this study was to determine the frequency of vitamin D deficiency and/or insufficiency in children with juvenile idiopathic arthritis (JIA) and familial Mediterranean fever (FMF) and to assess the relationship between vitamin D and disease activity. Sixty four patients with JIA, thirty six patients with FMF and one hundred healthy children were enrolled in this study. Vitamin D levels were measured during activation and remission periods in the patients with JIA and during attack and attack free periods in the patients with FMF. The mean vitamin D levels were found to be 18. 9±11 ng/ml and 18.6±9.2 ng/ml during activation and remission periods of disease, respectively, in the patients with JIA, 16±8.5 ng/ml and 13.1±6.4 ng/ml during attack and attack-free periods, respectively, in the patients with FMF and 26.7±10.5 ng/ml in the healthy children. There was no significant difference between vitamin D levels during activation and remission periods in the patients with JIA, whereas vitamin D levels during attack free periods were lower compared to attack periods in the patients with FMF. No significant relationship was found between disease activity and serum vitamin D levels. The vitamin D levels of the children with JIA and FMF were significantly lower compared to the healthy children. The frequency of vitamin D deficiency and insufficiency was considerably high among the patients with JIA and FMF.
Hypovitaminosis D is an important public health problem and affects children all around the world. Several studies have also reported high percentages of vitamin D deficiency and insufficiency during childhood [1] [2] [3] [4] . In addition to the role of vitamin D in bone mineralization and calcium metabolism; it has immunomodulatory effect on innate and adaptive immunity. It is speculated that abnormalities in vitamin D metabolism cause the release of proinflammatory cytokines inhibiting regulatory T cell production [5] [6] . Several studies have reported a relationship between vitamin D deficiency/insufficiency and chronic autoinflammatory disorders [7] [8] .
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disorder in children and a significant cause of both short and long-term disabilities. It is a multifactorial inflammatory disease characterized by persistent joint inflammation which manifests as swelling, pain and limitation of movement [9] [10] [11] . The fact that vitamin D inactivates Th1 and Th17, both of which are thought to have a role in JIA pathophysiology, supports the claim that there may be a relationship between vitamin D deficiency and JIA 12, 13 . However, data regarding the association between disease activity and serum vitamin D levels in children with JIA are limited.
Familial Mediterranean fever (FMF) is the most common hereditary autoinflammatory disorder characterized by recurrent episodes of fever and inflammation resulting in peritonitis, pleuritis, arthritis and erysipelas-like rash. Despite being the most common periodic fever, the factors triggering and terminating these spells are not completely understood 14 . In several studies, inverse correlation was found between disease activity and serum vitamin D levels in patients with FMF [15] [16] [17] .
The aim of this study was to determine the prevalence of vitamin D deficiency and/or insufficiency and to investigate the relationship between vitamin D and disease activity in patients with JIA and FMF.
Material and Methods
The participants of this cross-sectional study included 64 patients who presented to the Pediatric Rheumatology outpatient clinic of Cerrahpasa School of Medicine between March 2013 and February 2014 and were diagnosed with JIA according to the classification criteria of the International League of Associations for Rheumatology (ILAR) 18 and 36 patients with FMF diagnosed using the criteria set by Yalcinkaya 19 . The control group was composed of 100 healthy children matched for age and sex.
The serum 25(OH) vitamin D levels were evaluated during activation and remission periods of disease in the patients with JIA and during attack and attack free periods in the patients with FMF. The patients who were found to have active disease with clinical and laboratory assessment were included in the study. The number of joints with active inflammation was recorded for patients with JIA. The results of the Physician Visual Analog Scale (VAS Physician) which is used by physicians to assess the general disease activity and the results of the Family Visual Analog Scale (VAS Family) which is used by patients and families to asess the general wellbeing were also included in the evaluation. In these scales, "0" is the best score, while "10" is the worst 20 This study was approved by the local ethical committee. All children and their parents were informed about the details of the study and written consent was obtained from the parents of the children involved.
Results
The mean age was 9.7±4.3 years during disease activation period in the patients with JIA, 11.4±4.4 years during attack period in the patients with FMF and 9.9±4.1 years in the control group. Forty one (64%) of the patients with JIA and 18 (50%) of the patients with FMF were female. There was no significant difference in the sex and age distribution between the groups (p=0.17 and p=0.18, respectively). The clinical and demographic characteristics of the patients with JIA and FMF are presented in Table I and Table II. We found normal calcium, phosphate and alkaline phosphatase levels both in the healthy control group and in the patient group (data not shown). The mean vitamin D levels of the patients with JIA and FMF are given in Table  III . The patient groups were divided into four groups with respect to their vitamin D levels (data are given in Table IV ).
There was no significant difference between vitamin D levels of the patients with JIA during activation and remission periods, whereas vitamin D levels of the patients with FMF were lower during the attack free periods compared to the attack periods (p<0,01). There was no significant difference between the patients with JIA who were in the activation period and the patients with FMF who were in the attack period in terms of serum 25(OH) vitamin D levels (p=0.37). The serum 25(OH) vitamin D levels in the attack free periods in the patients with FMF were found to be significantly lower compared to the values found in the remission periods in the patients with JIA (p=0.007). A high prevalence of vitamin D deficiency and insufficiency was found both in the patient groups and healthy control group as shown in Table IV .
Discussion
The present study showed that serum 25(OH) vitamin D levels in both activation and remission periods were significantly lower in the patients with JIA compared to the healthy controls. Pelajo et al. 22 reported that there was no correlation between JIA disease activity and serum 25(OH) vitamin D levels. They suggested that several aspects such as drug regiments which modify the disease course, vitamin D supplements and limited exposure to sunlight due to long-term restriction of movement might affect vitamin D levels. Similarly, we did not find any correlation between disease activity and serum 25(OH) vitamin D level. Furthermore, there was no correlation between vitamin D levels and the parameters used in assessing the disease activity (CRP, joints with arthritis, VAS) and drug regimens. Munekata et al. 23 did not find a significant difference between healthy children and children with JIA in terms of vitamin D levels and therefore could not associate disease activity with vitamin D level. However, they detected high levels of vitamin D deficiency and insufficiency in healthy children and patients (deficiency was found with a rate of 26.7% and insufficiency was found with a rate of 46.7% in the patients with JIA; deficiency was found with a rate of 16.7% and insufficiency was found with a rate of 60% in the healthy children). In a crosssectional study conducted by Bouaddi et al. 24 with Moroccan children, 75% of the patients with JIA were found to be vitamin D deficient. However, no correlation was demonstrated between vitamin D level and disease activity. On the other hand, several studies conducted with RA patients showed an inverse correlation between disease activity and serum vitamin D level [25] [26] [27] [28] [29] [30] [31] . 
